Related Experiment Video
Updated: Jun 26, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data
C Paris1, S Thierry, P Brochard
1U954 INSERM, Vandoeuvre-les-Nancy Cedex, France. christophe.paris@nancy.inserm.fr
The European Respiratory Journal
|January 9, 2009
Summary
This study on asbestos-exposed workers found time since first exposure and cumulative exposure are linked to pleural plaques. Asbestosis risk is associated with cumulative asbestos exposure, highlighting key factors for screening.
Area of Science:
- Occupational Medicine
- Radiology
- Pulmonary Medicine
Background:
- Chest radiographs limit understanding of asbestos-related disease dose-response relationships.
- High-resolution computed tomography (HRCT) offers advanced diagnostics for asbestos exposure.
- Previous research has not fully elucidated exposure parameters linked to specific asbestos-related conditions.
Purpose of the Study:
- To identify key asbestos exposure parameters associated with pleural plaques and asbestosis.
- To utilize HRCT for diagnosing asbestos-related diseases in a large cohort.
- To establish dose-response and time-response relationships for asbestos exposure and disease.
Main Methods:
- Systematic HRCT screening of 5,545 formerly asbestos-exposed French workers (2003-2005).
- Analysis of time since first exposure (TSFE), exposure level, duration, and cumulative exposure.
- Adjusted unconditional logistic regression models to assess disease associations.
Main Results:
- TSFE and cumulative exposure independently associated with pleural plaques (p<0.0001, p=0.02).
- Cumulative exposure significantly associated with asbestosis (p<0.0001).
- Significant trend tests observed for all analyzed exposure parameters.
Conclusions:
- Demonstrated time-response and dose-response relationships for pleural plaques.
- Established dose-response relationships for asbestosis.
- Recommended incorporating TSFE and cumulative exposure in HRCT screening for high-risk populations.
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.